Epstein-Barr virus-associated infectious mononucleosis and risk of systemic lupus erythematosus

Rheumatology

Volumn 49, Issue 9, 2010, Pages 1706-1712

  Ulff møller, Constance J ^a   Nielsen, Nete M ^a   Rostgaard, Klaus ^a   Hjalgrim, Henrik ^a   Frisch, Morten ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

Autoimmune diseases; Cohort studies; Denmark; Epidemiology; Epstein Barr virus; Infectious mononucleosis; Risk factor; Systemic lupus erythematosus

Indexed keywords

HETEROPHILE ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOASSAY; INFECTIOUS MONONUCLEOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DENMARK; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; INFECTIOUS MONONUCLEOSIS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 77955719163     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq148     Document Type: Article

References (39)

1. D'Cruz DP. Systemic lupus erythematosus. Br Med J 2006;332:890-4.
2. Dror Y, Blachar Y, Cohen P, Livni N, Rosenmann E, Ashkenazi A. Systemic lupus erythematosus associated with acute Epstein-Barr virus infection. Am J Kidney Dis 1998;32:825-8.
3. Verdolini R, Bugatti L, Giangiacomi M, Nicolini M, Filosa G, Cerio R. Systemic lupus erythematosus induced by Epstein-Barr virus infection. Br J Dermatol 2002;146: 877-81.
4. Bhimma R, Adhikari M, Coovadia HM. Epstein-Barr virus-induced systemic lupus erythematosus. S Afr Med J 1995;85:899-900.
5. Evans AS. Clinical syndromes associated with EB virus infection. Adv Intern Med 1972;18:77-93.
6. Rothfield NF, Evans AS, Niederman JC. Clinical and laboratory aspects of raised virus antibody titres in systemic lupus erythematosus. Ann Rheum Dis 1973;32: 238-46.
7. Lu JJ, Chen DY, Hsieh CW, Lan JL, Lin FJ, Lin SH. Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan. Lupus 2007;16: 168-75.
8. James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997;100:3019-26.
9. James JA, Neas BR, Moser KL et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 2001;44: 1122-6.
10. Kang I, Quan T, Nolasco H et al. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol 2004;172:1287-94.
11. Moon UY, Park SJ, Oh ST et al. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther 2004;6: R295-302.
12. Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33.
13. James JA, Harley JB. Linear epitope mapping of an Sm B/B0 polypeptide. J Immunol 1992;148:2074-9.
14. James JA, Gross T, Scofield RH, Harley JB. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B0-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 1995;181:453-61.
15. Poole BD, Gross T, Maier S, Harley JB, James JA. Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments. J Autoimmun 2008;31:362-71.
16. McClain MT, Rapp EC, Harley JB, James JA. Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1. J Med Virol 2003;70:253-7.
17. Strom BL, Reidenberg MM, West S, Snyder ES, Freundlich B, Stolley PD. Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus. Am J Epidemiol 1994;140:632-42.
18. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS. Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history. J Clin Epidemiol 2002;55:982-9.
19. Pedersen CB, Gøtzsche H, Møller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006;53:441-9.
20. Kristensen M. Studies on the sero-diagnosis of mononucleosis infectiosa. Acta Pathol Microbiol Immunol Scand 1938;15(Suppl. 37):339-56.
21. Haahr S, Koch-Henriksen N, Møller-Larsen A, Eriksen LS, Andersen HM. Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study. Mult Scler 1995;1:73-7.
22. Rosdahl N, Larsen SO, Clemmesen J. Hodgkin's disease in patients with previous infectious mononucleosis: years' experience. Br Med J 1974;2:253-6.
23. Nielsen TR, Rostgaard K Nielsen NM et al. Multiple sclerosis after infectious mononucleosis. Arch Neurol 2007;64:72-5.
24. Hjalgrim H, Askling J, Rostgaard K et al. Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med 2003;349:1324-32.
25. Andersen TF, Madsen M, Jørgensen J, Mellemkjær L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-8.
26. Ulff-Møller CJ, Jørgensen KT, Pedersen BV, Nielsen NM, Frisch M. Reproductive factors and risk of systemic lupus erythematosus: nationwide cohort study in Denmark. J Rheumatol 2009;36:1903-9.
27. Nielsen NM, Frisch M, Rostgaard K et al. Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives. Mult Scler 2008;14:823-9.
28. Jørgensen KT, Rostgaard K, Bache I et al. Autoimmune diseases in women with Turner syndrome. Arthritis Rheum 2010;62:658-66.
29. Niller HH, Wolf H, Minarovits J. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Autoimmunity 2008;41:298-328.
30. Barzilai O, Ram M, Shoenfeld Y. Viral infection can induce the production of autoantibodies. Curr Opin Rheumatol 2007;19:636-43.
31. Zandman-Goddard G, Shoenfeld Y. Infections and SLE. Autoimmunity 2005;38:473-85.
32. Katz BZ, Salimi B, Kim S, Nsiah-Kumi P, Wagner-Weiner L. Epstein-Barr virus burden in adolescents with systemic lupus erythematosus. Pediatr Infect Dis J 2001;20:148-53.
33. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008;358:929-39.
34. Hurt C, Tammaro D. Diagnostic evaluation of mononucleosis-like illnesses. Am J Med 2007;120:911-8.
35. Voss A, Green A, Junker P. Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort. Scand J Rheumatol 1998;27: 98-105.
36. Evans AS, Niederman JC, Cenabre LC, West B, Richards VA. A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: specificity and sensitivity of the tests and persistence of antibody. J Infect Dis 1975;132:546-54.
37. Bruu AL, Hjetland R, Holter E et al. Evaluation of commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin Diagn Lab Immunol 2000;7:451-6.
38. Hoagland RJ. Infectious mononucleosis. Prim Care 1975; 2:295-307.
39. Linderholm M, Boman J, Juto P, Linde A. Comparative evaluation of nine kits for rapid diagnosis of infectious mononucleosis and Epstein-Barr virus-specific serology. J Clin Microbiol 1994;32:259-61.